1 December, 2023“Clinical trials are a hope for patients with rare diseases and already account for 25% of all research done in Spain”.Farmaindustria’s CEO, Juan Yermo, participates in the conference ‘Towards a Comprehensive European Plan: Spain’s involvement with Rare Diseases’, organised by Feder in the Spanish Congress of […]